Brown seaweed with anti-obesity potential!

Key points
- Scientists believe they may have found something to combat obesity and it may also help prevent the onset of diabetes.
- The find, an edible seaweed containing the carotenoid fucoxanthin, when fed to rats enabled them to shed 10% of their body weight, mainly from around the gut.
- Fucoxanthin is found at high levels in several different types of brown seaweed but not in green and red seaweeds and is tightly bound to proteins in the seaweed and not easily absorbed in its natural form.
- Brown seaweed, also known as wakame, is a key ingredient in Japanese miso soup but the researchers say drinking large quantities of the soup in an effort to lose weight would have little effect.
Scientists believe they may have found something to combat obesity and it may also help prevent the onset of diabetes.
The find, an edible seaweed containing the carotenoid fucoxanthin, when fed to rats enabled them to shed 10% of their body weight, mainly from around the gut.
Fucoxanthin is found at high levels in several different types of brown seaweed but not in green and red seaweeds and is tightly bound to proteins in the seaweed and not easily absorbed in its natural form.
Brown seaweed, also known as wakame, is a key ingredient in Japanese miso soup but the researchers say drinking large quantities of the soup in an effort to lose weight would have little effect.
The researchers from Hokkaido University hope that fucoxanthin can be developed into a slimming supplement or a drug that targets harmful fat.
Lead researcher Dr. Kazuo Miyashita, says it might be another three to five years before a slimming pill based on fucoxanthin was available to the public.
Dr. Miyashita's team studied the effects of fucoxanthin on more than 200 rats and mice and found it was effective in fighting flab in two ways; in obese animals, the compound appeared to stimulate a protein called UCP1 which causes fat to be broken down; and the pigment also caused the liver to produce a compound called docosahexaenoic acid (DHA), which can help cut levels of "bad" cholesterol associated with obesity and heart disease.
The protein UCP1 is found in the white fat adipose tissue, which is responsible for "middle-age spread" and excess amounts of fat around the midriff are particularly linked to heart disease and diabetes.
No adverse side effects were seen in the animals used in the study but experts caution that medication, however good, is not enough and only a significant change in lifestyle will ever achieve long-term weight loss.
Previous studies by Miyashita's team have shown that fucoxanthin also helps promote the death of human prostate cancer cells in the lab.
Their findings suggest that fucoxanthin has potential as a preventive agent for a variety of diseases.
The research was presented to an American Chemical Society meeting in San Francisco.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Weight & Nutrition →
NewsObesity And Environmental Chemicals: Research Probes Potential Link
Could your couch be making you fat? A team of researchers at UNH is investigating whether the increasing ubiquity of chemical flame retardants found in foam furniture, carpeting, microwaves and computers might be…
8 March 2007
NewsAnti-obesity vaccine keeps rats trim
Researchers at the Scripps Research Institute in California in the U.S. have developed an anti-obesity vaccine that significantly slowed weight gain and reduced body fat in rats even when they over ate. The team say the…
2 August 2006
NewsSerotonin Reduces Appetite, Could Help in Developing Safer Anti-Obesity Drugs
A study led by a UT Southwestern Medical Center researcher sheds light on how the brain chemical serotonin, when spurred by diet drugs such as Fen-phen, works to curb appetite. That knowledge could aid in the design of…
20 July 2006


